Personalised Medicine: Moving from Promise to Practice
Modern medicine and the drug development process have long been directed by the law of averages, aimed at greatest effect across the largest number of patients. Yet this concept is economically wasteful and flawed in terms of individual patient outcomes. Exciting developments in diagnostics and biomarkers over recent years promise better targeting and theoretically close to 100% likelihood of treatment success.
Locations: Basel (Switzerland), New Jersey (USA), Paris (France)
“Personalised medicine, driven by exciting scientific breakthrough developments in diagnostics and biomarkers provides the opportunity for extremely efficient success rates – so what are we waiting for?”